IT & Data Management
IT & Data Management
Focusing on Cutting-edge Biopharmaceutical Technologies, Boosting the Industry to...
To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry--- bioLIVE China...
IT & Data Management
AT & IT China 2020, to be held alongside...
AT & IT China 2020, organized by Informa Markets and China Chamber of Commerce for Import & Export of Medicines & Health Products and co-organized...
IT & Data Management
15 Years of P-MEC China Driving Global Pharma Technology...
P-MEC China, co-organized by Informa Markets, CCCMHPIE and Sinoexpo Informa Markets, will take place at the Shanghai New International Expo Center (SNIEC) on 22-24 June...
IT & Data Management
Patient-Data Platform Raremark Enhances Executive Team to Accelerate Progress...
Raremark, the leading patient-data platform in rare disease, is pleased to announce additions to its executive team to speed the company’s pursuit of more treatments...
IT & Data Management
Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer...
a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, announced that it has entered into a licensing and development agreement...
IT & Data Management
Enhanced Chromatography Data System Software Delivers Improved Efficiency and...
Thermo Fisher Scientific and Agilent Technologies announced they are continuing their agreement to the industry-wide Instrument Control Exchange Program (ICEP) – fostering compatibility among key...
IT & Data Management
Neuraxpharm expands Southern Europe operations with Portugal unit
European speciality pharmaceutical company Neuraxpharm Group has announced the launch of Neuraxpharm Portugal as part of an expansion of its operations in Southern Europe.
Neuraxpharm Portugal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.